Innovation in
Vectorized
Intrabodies.
Vybion is the leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical needs. Vybion Intrabodies are scFv fragments that target and change the fate of intracellular events like the protein aggregation, gene dysregulation and turnover of toxic protein fragments as a disease modifying approach to therapeutics.
Huntington’s Disease
Huntington’s disease is uniformly fatal in 15-20 years after diagnosis typically at an age range of 35-45. Huntington’s is characterized by a loss of both motor and cognitive function. INT41 is a disease modifying drug that can be delivered a plasmid DNA intranasally in an exosome, a natural vesicle that transfers information between cells and travels along neural pathways.